|
|||||
|
|
| 整合医药研发与评价资源，建立“中国卒中新药研发产业联盟” | |
| 引用本文： | 王志江,王伊龙,赵志刚,王拥军. 整合医药研发与评价资源，建立“中国卒中新药研发产业联盟”[J]. 药品评价, 2010, 7(4): 16-18 |
| 作者姓名： | 王志江 王伊龙 赵志刚 王拥军 |
| 作者单位： | 1. 首都医科大学附属北京天坛医院科研处,北京,100050 2. 首都医科大学附属北京天坛医院科研处,北京,100050;首都医科大学附属北京天坛医院神经内科,北京,100050 3. 首都医科大学附属北京天坛医院药剂科,北京,100050 4. 首都医科大学附属北京天坛医院神经内科,北京,100050 |
| 基金项目： | 国家科技重大专项--重大新药创制:脑血管病创新药物临床评价技术平台建立 |
| 摘 要： | 目的：提出建立”中国卒中新药研发产业联盟”的意义、目标和规划。方法：文献检索及专家咨询。结果与结论：建立和发展卒中新药研发产业联盟,定期召开卒中治疗企业与临床机构共识会议,有利于促进卒中领域新药和器械的研发与评价。 |
| 关 键 词： | 医药研发 资源评价 中国卒中新药研发产业联盟 |
Establishment of China Stroke Drugs Discovery Alliance by Integrating Resources of Drugs Discovery and Evaluation |
|
| WANG Zhi-jiang,WANG Yi-long,ZHAO Zhi-gang,WANG Yong-jun. Establishment of China Stroke Drugs Discovery Alliance by Integrating Resources of Drugs Discovery and Evaluation[J]. Drug Evaluation, 2010, 7(4): 16-18 | |
| Authors: | WANG Zhi-jiang WANG Yi-long ZHAO Zhi-gang WANG Yong-jun |
| Affiliation: | 1. Department of scientific research, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing 100050 2. Department of neurology, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing 100050 3. Department of pharmacy, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing 100050) |
| Abstract: | Objective： To introduce the significance, goals and planning of setting up ＂ China Stroke Drugs Discovery Alliance ＂. Methods： Literature search and experts consultation. Results and Conclusion： The establishment and development of the Stroke Drug Discovery Alliance and organization of the stroke treatment academic industry and clinical study institute consensus conferences will improve our understanding of issues critical to stroke drugs and devices development and advance knowledge essential to the successful development of new stroke treatments. |
| Keywords: | Pharmaceutical research and development Resource assessment China Stroke Drugs Discovery Alliance |
| 本文献已被 维普 万方数据 等数据库收录！ | |